S. Lockton

935 total citations
13 papers, 736 citations indexed

About

S. Lockton is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, S. Lockton has authored 13 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Genetics and 5 papers in Immunology. Recurrent topics in S. Lockton's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). S. Lockton is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). S. Lockton collaborates with scholars based in United States, United Kingdom and Canada. S. Lockton's co-authors include Paul T. Quinlan, James Irwin, Aimee L. Lucas, Sharat Singh, Scott Hauenstein, Niels Vande Casteele, Paul Rutgeerts, Séverine Vermeire, Ann Gils and Guangyong Zou and has published in prestigious journals such as Gut, Molecular Biology and Evolution and Alimentary Pharmacology & Therapeutics.

In The Last Decade

S. Lockton

13 papers receiving 715 citations

Peers

S. Lockton
Alon D. Levin Netherlands
Roni Weisshof United States
Abdul Elkadri United States
Thomas Klag Germany
Xavier Bossuyt Belgium
Yasuo Takekoshi Japan
Nielsen Am Denmark
Alfreda Krupoves Canada
N. Sapone Italy
Stephen B. Hanauer United States
Alon D. Levin Netherlands
S. Lockton
Citations per year, relative to S. Lockton S. Lockton (= 1×) peers Alon D. Levin

Countries citing papers authored by S. Lockton

Since Specialization
Citations

This map shows the geographic impact of S. Lockton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Lockton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Lockton more than expected).

Fields of papers citing papers by S. Lockton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Lockton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Lockton. The network helps show where S. Lockton may publish in the future.

Co-authorship network of co-authors of S. Lockton

This figure shows the co-authorship network connecting the top 25 collaborators of S. Lockton. A scholar is included among the top collaborators of S. Lockton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Lockton. S. Lockton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Park, Silvia, Emma Langley, Jong‐Mu Sun, et al.. (2015). Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer. Oncotarget. 6(31). 30929–30938. 10 indexed citations
2.
Casteele, Niels Vande, Reena Khanna, Barrett G. Levesque, et al.. (2014). The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease. Gut. 64(10). 1539–1545. 224 indexed citations
3.
Baert, Filip, David Drobne, Ann Gils, et al.. (2014). Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy. Clinical Gastroenterology and Hepatology. 12(9). 1474–1481.e2. 99 indexed citations
4.
Levesque, Barrett G., Gordon R. Greenberg, Guangyong Zou, et al.. (2014). A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Alimentary Pharmacology & Therapeutics. 39(10). 1126–1135. 82 indexed citations
5.
Noben, Manuel, Anthony de Buck van Overstraeten, S. Lockton, et al.. (2014). DOP052 Active smoking, and pre-operative anti-flagellin Fla2 and pANCA antibodies may predict postoperative Crohn's disease recurrence: results from a prospective mono-centric trial. Journal of Crohn s and Colitis. 8. S39–S40. 1 indexed citations
6.
Billiet, Thomas, Magali de Bruyn, Karolien Claes, et al.. (2014). P566 A matrix-based prediction model for primary response to infliximab in Crohn's disease patients. Journal of Crohn s and Colitis. 8. S303–S304. 1 indexed citations
7.
Plevy, Scott E., Mark S. Silverberg, S. Lockton, et al.. (2013). Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohnʼs Disease, and Ulcerative Colitis Patients. Inflammatory Bowel Diseases. 19(6). 1139–1148. 97 indexed citations
8.
9.
Meisel, Richard P., et al.. (2010). Adaptive Evolution of Genes Duplicated from the Drosophila pseudoobscura neo-X Chromosome. Molecular Biology and Evolution. 27(8). 1963–1978. 14 indexed citations
10.
Macdonald, Catherine, et al.. (2003). Microsatellite isolation and characterization in the beneficial parasitoid wasp Diaeretiella rapae (M’Intosh) (Hymenoptera: Braconidae: Aphidiinae). Molecular Ecology Notes. 3(4). 601–603. 6 indexed citations
11.
Quinlan, Paul T., S. Lockton, James Irwin, & Aimee L. Lucas. (1995). The Relationship between Stool Hardness and Stool Composition in Breast- and Formula-Fed Infants. Journal of Pediatric Gastroenterology and Nutrition. 20(1). 81–90. 171 indexed citations
12.
Quinlan, Paul T., S. Lockton, James Irwin, & Aimee L. Lucas. (1995). The Relationship between Stool Hardness and Stool Composition in Breast‐ and Formula‐Fed Infants. Journal of Pediatric Gastroenterology and Nutrition. 20(1). 81–90. 24 indexed citations
13.
Lucas, Alexandra, S. Lockton, & P. S. W. Davies. (1991). Milk for babies and children. BMJ. 302(6772). 350–351. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alon D. Levin Breakdown of academic impact, for papers by Roni Weisshof Breakdown of academic impact, for papers by Abdul Elkadri Breakdown of academic impact, for papers by Thomas Klag Breakdown of academic impact, for papers by Xavier Bossuyt Breakdown of academic impact, for papers by Yasuo Takekoshi Breakdown of academic impact, for papers by Nielsen Am Breakdown of academic impact, for papers by Alfreda Krupoves Breakdown of academic impact, for papers by N. Sapone Breakdown of academic impact, for papers by Stephen B. Hanauer
Rankless by CCL
2026